| Literature DB >> 22183843 |
Elissa Meites1, Eloisa Llata, Susan Hariri, Jonathan Zenilman, Lisa Longfellow, Jane Schwebke, Irina Tabidze, Christie Mettenbrink, Heidi Jenkins, Sarah Guerry, Preeti Pathela, Lenore Asbel, Jeffrey A Stover, Kyle Bernstein, Roxanne P Kerani, Eileen F Dunne, Lauri E Markowitz.
Abstract
We surveyed selected public sexually transmitted disease clinics in the United States regarding human papillomavirus vaccine availability, target populations, funding sources, and barriers. Although nearly all had experience offering other vaccines, only 7 of 42 clinics (17%) offered human papillomavirus vaccine. Vaccine cost, staff time, and follow-up issues were commonly reported barriers.Entities:
Mesh：
Substances：
Year: 2012 PMID： 22183843 DOI： 10.1097/OLQ.0b013e3182315584
Source DB: PubMed Journal: Sex Transm Dis ISSN： 0148-5717 Impact factor: 2.830